FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - Deutsche Boerse AG 15:50:43 2024-05-31 EDT | ||
| 680 EUR | +0.19% |
|
| 1 month | +19.46% | ||
| 3 months | +64.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 680 | +0.19% |
| 24-05-30 | 678.8 | -0.92% |
| 24-05-29 | 685 | -0.62% |
| 24-05-28 | 689.3 | -8.72% |
| 24-05-27 | 755.2 | +4.49% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:50 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC6BSX |
| ISIN | DE000PC6BSX7 |
| Date issued | 2022-11-04 |
| Strike | 75 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 767.4 € |
|---|---|
| Lowest since issue | 84.86 € |
| Spread | 7.54 € |
| Spread % | 1.05% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
75.57
USD
Average target price
82.06
USD
Spread / Average Target
+8.59%
- Stock Market
- Certificates
- Certificat
